Targeted Asthma Therapy

Developer: MedLearning2017

Category: Medical

2 installs

ratings

ASO Keyword Dashboard

Tracking 60 keywords for Targeted Asthma Therapy in Google Play

Developer: MedLearning2017 Category: medical

Targeted Asthma Therapy tracks 60 keywords (no keywords rank yet; 60 need traction). Key metrics: opportunity 69.6, difficulty 42.5.

Explore biologic therapies to improve outcomes in severe asthma

Tracked keywords

0 ranked • 60 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

69.6

Top keyword: compare

Avg difficulty

42.5

Lower scores indicate easier wins

Opportunity leaders

compare

Opportunity: 73.0 • Difficulty: 49.7 • Rank —

Competitors: 1,171
67.6
practical

Opportunity: 72.0 • Difficulty: 44.4 • Rank —

Competitors: 764
69.3
benefit

Opportunity: 72.0 • Difficulty: 44.8 • Rank —

Competitors: 802
68.9
approach

Opportunity: 72.0 • Difficulty: 54.7 • Rank —

Competitors: 440
65.2
optimize

Opportunity: 72.0 • Difficulty: 47.6 • Rank —

Competitors: 677
65.5

Unranked opportunities

compare

Opportunity: 73.0 • Difficulty: 49.7 • Competitors: 1,171
practical

Opportunity: 72.0 • Difficulty: 44.4 • Competitors: 764
benefit

Opportunity: 72.0 • Difficulty: 44.8 • Competitors: 802
approach

Opportunity: 72.0 • Difficulty: 54.7 • Competitors: 440
optimize

Opportunity: 72.0 • Difficulty: 47.6 • Competitors: 677

High competition keywords

provides

Total apps: 71,787 • Major competitors: 6,088

Latest rank: — • Difficulty: 60.0
data

Total apps: 68,455 • Major competitors: 6,589

Latest rank: — • Difficulty: 65.4
including

Total apps: 66,643 • Major competitors: 8,693

Latest rank: — • Difficulty: 64.4
latest

Total apps: 60,108 • Major competitors: 5,868

Latest rank: — • Difficulty: 65.1
explore

Total apps: 53,061 • Major competitors: 8,172

Latest rank: — • Difficulty: 67.9

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
program	71	100	47	73 19,009 competing apps Median installs: 26,294 Avg rating: 2.7	—	—	1,273 major competitor apps
including	67	100	64	82 66,643 competing apps Median installs: 40,188 Avg rating: 3.0	—	—	8,693 major competitor apps
explore	68	100	68	81 53,061 competing apps Median installs: 48,448 Avg rating: 3.1	—	—	8,172 major competitor apps
patients	71	100	39	60 3,336 competing apps Median installs: 19,052 Avg rating: 2.6	—	—	203 major competitor apps
provides	67	100	60	83 71,787 competing apps Median installs: 26,302 Avg rating: 2.7	—	—	6,088 major competitor apps
patient	71	100	38	61 3,718 competing apps Median installs: 18,204 Avg rating: 2.6	—	—	190 major competitor apps
practical	72	100	44	69 11,343 competing apps Median installs: 21,950 Avg rating: 2.5	—	—	764 major competitor apps
improve	68	100	56	80 46,984 competing apps Median installs: 36,014 Avg rating: 2.9	—	—	5,304 major competitor apps
benefit	72	100	45	69 10,780 competing apps Median installs: 26,900 Avg rating: 2.5	—	—	802 major competitor apps
type	70	100	58	75 25,324 competing apps Median installs: 37,985 Avg rating: 2.9	—	—	2,782 major competitor apps
approach	72	100	55	65 6,545 competing apps Median installs: 22,839 Avg rating: 2.8	—	—	440 major competitor apps
initiative	70	100	34	53 1,301 competing apps Median installs: 22,783 Avg rating: 2.1	—	—	80 major competitor apps
across	69	100	81	78 38,391 competing apps Median installs: 39,224 Avg rating: 3.0	—	—	5,234 major competitor apps
personalized	70	100	60	76 28,852 competing apps Median installs: 31,583 Avg rating: 3.0	—	—	3,359 major competitor apps
latest	67	100	65	82 60,108 competing apps Median installs: 30,299 Avg rating: 2.8	—	—	5,868 major competitor apps
optimize	72	100	48	66 6,817 competing apps Median installs: 24,096 Avg rating: 2.8	—	—	677 major competitor apps
data	67	100	65	83 68,455 competing apps Median installs: 26,834 Avg rating: 2.7	—	—	6,589 major competitor apps
global	71	100	59	74 20,081 competing apps Median installs: 42,215 Avg rating: 3.0	—	—	2,796 major competitor apps
participants	70	100	35	57 2,039 competing apps Median installs: 16,971 Avg rating: 2.4	—	—	94 major competitor apps
define	71	100	40	59 2,826 competing apps Median installs: 31,286 Avg rating: 3.0	—	—	318 major competitor apps
complex	72	100	51	70 12,139 competing apps Median installs: 28,210 Avg rating: 2.8	—	—	1,186 major competitor apps
role	72	100	46	67 8,269 competing apps Median installs: 46,652 Avg rating: 2.8	—	—	1,214 major competitor apps
explores	69	100	30	46 505 competing apps Median installs: 25,856 Avg rating: 2.8	—	—	49 major competitor apps
supporting	72	100	44	64 5,319 competing apps Median installs: 28,117 Avg rating: 2.9	—	—	502 major competitor apps
improving	72	100	46	67 8,831 competing apps Median installs: 29,578 Avg rating: 2.9	—	—	854 major competitor apps

App Description

Explore biologic therapies to improve outcomes in severe asthma

Asthma is a complex and heterogeneous chronic disease that manifests differently across patient populations, influenced by factors such as age, ethnicity, and comorbid conditions. This program explores the underlying role of type 2 inflammation in asthma pathophysiology and highlights how biomarkers—including eosinophil counts, fractional exhaled nitric oxide (FeNO), and IgE levels—can inform a more personalized approach to treatment. Participants will examine emerging evidence supporting the use of biomarker testing to define asthma phenotypes and optimize therapeutic strategies.

Building on the latest Global Initiative for Asthma (GINA 2025) recommendations, this provides guidance on assessing disease severity, evaluating comorbidities, and identifying patients most likely to benefit from biologic therapy. Clinical data and practical decision-making frameworks will be reviewed that compare anti-IgE, anti–IL-5/5R, anti–IL-4/13, and anti–TSLP biologics, emphasizing their safety, efficacy, and demonstrated benefits in reducing exacerbations and improving lung function.